Virus engineering: functionalization and stabilization.

Chemically and/or genetically engineered viruses, viral capsids and viral-like particles carry the promise of important and diverse applications in biomedicine, biotechnology and nanotechnology. Potential uses include new vaccines, vectors for gene therapy and targeted drug delivery, contrast agents for molecular imaging and building blocks for the construction of nanostructured materials and electronic nanodevices. For many of the contemplated applications, the improvement of the physical stability of viral particles may be critical to adequately meet the demanding physicochemical conditions they may encounter during production, storage and/or medical or industrial use. The first part of this review attempts to provide an updated general overview of the fast-moving, interdisciplinary virus engineering field; the second part focuses specifically on the modification of the physical stability of viral particles by protein engineering, an emerging subject that has not been reviewed before.

[1]  B. Kay,et al.  Filamentous phage display in the new millennium. , 2005, Chemical reviews.

[2]  Vladimir P Zharov,et al.  Covalently linked Au nanoparticles to a viral vector: potential for combined photothermal and gene cancer therapy. , 2006, Nano letters.

[3]  C. Ozkan,et al.  Digital memory device based on tobacco mosaic virus conjugated with nanoparticles , 2006, Nature nanotechnology.

[4]  Kent Kirshenbaum,et al.  Nano-tailoring; stitching alterations on viral coats. , 2004, Chemistry & biology.

[5]  Andries Zijlstra,et al.  Viral nanoparticles as tools for intravital vascular imaging , 2006, Nature Medicine.

[6]  Peter G Stockley,et al.  Engineering thermal stability in RNA phage capsids via disulphide bonds. , 2005, Journal of nanoscience and nanotechnology.

[7]  John E. Johnson,et al.  An engineered virus as a scaffold for three-dimensional self-assembly on the nanoscale. , 2005, Small.

[8]  Mauricio G Mateu,et al.  Manipulation of the mechanical properties of a virus by protein engineering , 2008, Proceedings of the National Academy of Sciences.

[9]  Mauricio G. Mateu,et al.  Engineering Viable Foot-and-Mouth Disease Viruses with Increased Thermostability as a Step in the Development of Improved Vaccines , 2008, Journal of Virology.

[10]  Maria Kontou,et al.  Structural Determinants of Tissue Tropism and In Vivo Pathogenicity for the Parvovirus Minute Virus of Mice , 2005, Journal of Virology.

[11]  Jana L Phillips,et al.  Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle , 2010, Nature Biotechnology.

[12]  J. Hogle Poliovirus cell entry: common structural themes in viral cell entry pathways. , 2002, Annual review of microbiology.

[13]  D. Muruve,et al.  Immunity to adeno-associated virus vectors in animals and humans: a continued challenge , 2008, Gene Therapy.

[14]  Robert L. Garcea,et al.  Intercapsomeric Disulfide Bonds in Papillomavirus Assembly and Disassembly , 1998, Journal of Virology.

[15]  P. Tattersall,et al.  Parvoviral host range and cell entry mechanisms. , 2007, Advances in virus research.

[16]  M. Young,et al.  A library of protein cage architectures as nanomaterials. , 2009, Current topics in microbiology and immunology.

[17]  Mauricio G Mateu,et al.  In Vitro Disassembly of a Parvovirus Capsid and Effect on Capsid Stability of Heterologous Peptide Insertions in Surface Loops* , 2004, Journal of Biological Chemistry.

[18]  E. Donath,et al.  Biosensors: Viruses for ultrasensitive assays. , 2009, Nature nanotechnology.

[19]  Zahi A Fayad,et al.  Modified natural nanoparticles as contrast agents for medical imaging. , 2010, Advanced drug delivery reviews.

[20]  R. Samulski,et al.  Adeno-associated virus serotypes: vector toolkit for human gene therapy. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[21]  Qian Wang,et al.  Bioconjugation by copper(I)-catalyzed azide-alkyne [3 + 2] cycloaddition. , 2003, Journal of the American Chemical Society.

[22]  Y. Chiang,et al.  Virus-Enabled Synthesis and Assembly of Nanowires for Lithium Ion Battery Electrodes , 2006, Science.

[23]  John E. Johnson,et al.  Hybrid virus-polymer materials. 1. Synthesis and properties of PEG-decorated cowpea mosaic virus. , 2003 .

[24]  Jacob M Hooker,et al.  Interior surface modification of bacteriophage MS2. , 2004, Journal of the American Chemical Society.

[25]  T. Conlon,et al.  Mutational Analysis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Construction of AAV2 Vectors with Altered Tropism , 2000, Journal of Virology.

[26]  Chuanbin Mao,et al.  Virus-based chemical and biological sensing. , 2009, Angewandte Chemie.

[27]  Trevor Douglas,et al.  Host–guest encapsulation of materials by assembled virus protein cages , 1998, Nature.

[28]  P. Vogt,et al.  Cell entry by non-enveloped viruses. , 2010, Current topics in microbiology and immunology.

[29]  Steven Henikoff,et al.  Affinity Selection from Biological Libraries , 2002, Science.

[30]  Matti Leisola,et al.  Protein engineering: opportunities and challenges , 2007, Applied Microbiology and Biotechnology.

[31]  A. Asokan,et al.  Bioluminescent virion shells: new tools for quantitation of AAV vector dynamics in cells and live animals , 2008, Gene Therapy.

[32]  F PRZESMYCKI,et al.  [Biology of viruses]. , 1953, Postepy higieny i medycyny doswiadczalnej.

[33]  M. Finn,et al.  Chemical modification of viruses and virus-like particles. , 2009, Current topics in microbiology and immunology.

[34]  W. Stemmer,et al.  Breeding of retroviruses by DNA shuffling for improved stability and processing yields , 2000, Nature Biotechnology.

[35]  J. Almendral,et al.  Complementary Roles of Multiple Nuclear Targeting Signals in the Capsid Proteins of the Parvovirus Minute Virus of Mice during Assembly and Onset of Infection , 2002, Journal of Virology.

[36]  M. Croyle,et al.  Development of formulations that enhance physical stability of viral vectors for gene therapy , 2001, Gene Therapy.

[37]  Michael Hallek,et al.  Combinatorial engineering of a gene therapy vector: directed evolution of adeno‐associated virus , 2006, The journal of gene medicine.

[38]  Lars Liljas,et al.  The crystal structure of bacteriophage Qβ at 3.5 å resolution , 1996 .

[39]  R. Saffrich,et al.  Nuclear Export of the Nonenveloped Parvovirus Virion Is Directed by an Unordered Protein Signal Exposed on the Capsid Surface , 2004, Journal of Virology.

[40]  David Rowlands,et al.  The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution , 1989, Nature.

[41]  I. Yacoby,et al.  Killing cancer cells by targeted drug-carrying phage nanomedicines , 2008, BMC biotechnology.

[42]  M G Rossmann,et al.  Functional implications of the structure of the murine parvovirus, minute virus of mice. , 1998, Structure.

[43]  Jason Lanman,et al.  Investigation of N-terminal domain charged residues on the assembly and stability of HIV-1 CA. , 2004, Biochemistry.

[44]  Mark H Ellisman,et al.  An adenoviral platform for selective self-assembly and targeted delivery of nanoparticles. , 2008, Small.

[45]  Trevor Douglas,et al.  Structural transitions in Cowpea chlorotic mottle virus (CCMV) , 2005, Physical biology.

[46]  Young Keun Kim,et al.  A highly sensitive and selective diagnostic assay based on virus nanoparticles. , 2009, Nature nanotechnology.

[47]  Angela M Belcher,et al.  Programmable assembly of nanoarchitectures using genetically engineered viruses. , 2005, Nano letters.

[48]  W S Klug,et al.  Nanoindentation studies of full and empty viral capsids and the effects of capsid protein mutations on elasticity and strength. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[49]  John E. Johnson,et al.  Structures of the native and swollen forms of cowpea chlorotic mottle virus determined by X-ray crystallography and cryo-electron microscopy. , 1995, Structure.

[50]  C. Kempf,et al.  Low pH-Dependent Endosomal Processing of the Incoming Parvovirus Minute Virus of Mice Virion Leads to Externalization of the VP1 N-Terminal Sequence (N-VP1), N-VP2 Cleavage, and Uncoating of the Full-Length Genome , 2006, Journal of Virology.

[51]  Sierin Lim,et al.  Design of a pH-dependent molecular switch in a caged protein platform. , 2009, Nano letters.

[52]  S. Zhou,et al.  Cys residues of the hepatitis B virus capsid protein are not essential for the assembly of viral core particles but can influence their stability , 1992, Journal of virology.

[53]  Anna Merzlyak,et al.  Genetically engineered nanofiber-like viruses for tissue regenerating materials. , 2009, Nano letters.

[54]  A Carreira,et al.  DNA-mediated anisotropic mechanical reinforcement of a virus , 2006, Proceedings of the National Academy of Sciences.

[55]  D I Stuart,et al.  Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids , 1995, Journal of virology.

[56]  Albert J R Heck,et al.  High-resolution mass spectrometry of viral assemblies: Molecular composition and stability of dimorphic hepatitis B virus capsids , 2008, Proceedings of the National Academy of Sciences.

[57]  M. S. Smyth,et al.  Picornavirus uncoating. (Review) , 2002 .

[58]  Trevor Douglas,et al.  VIRUS PARTICLES AS TEMPLATES FOR MATERIALS SYNTHESIS , 1999 .

[59]  Alasdair C. Steven,et al.  Molecular Tectonic Model of Virus Structural Transitions: the Putative Cell Entry States of Poliovirus , 2000, Journal of Virology.

[60]  Martin Fischlechner,et al.  Viruses as building blocks for materials and devices. , 2007, Angewandte Chemie.

[61]  Bengt Jönsson,et al.  Internal DNA pressure modifies stability of WT phage , 2007, Proceedings of the National Academy of Sciences.

[62]  David Barlam,et al.  Mechanical properties of murine leukemia virus particles: effect of maturation. , 2006, Biophysical journal.

[63]  Akihiko Kondo,et al.  The specific delivery of proteins to human liver cells by engineered bio‐nanocapsules , 2005, The FEBS journal.

[64]  P. Singh,et al.  Virus-based nanoparticles (VNPs): platform technologies for diagnostic imaging. , 2006, Advanced drug delivery reviews.

[65]  John E. Johnson,et al.  Enhanced Local Symmetry Interactions Globally Stabilize a Mutant Virus Capsid That Maintains Infectivity and Capsid Dynamics , 2006, Journal of Virology.

[66]  Matthias Paschke,et al.  Phage display systems and their applications , 2006, Applied Microbiology and Biotechnology.

[67]  D R Burton,et al.  Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. , 1989, Science.

[68]  P. Ross,et al.  Viral nano electronics. , 2006, Scientific American.

[69]  B. Charleston,et al.  Options for control of foot-and-mouth disease: knowledge, capability and policy , 2009, Philosophical Transactions of the Royal Society B: Biological Sciences.

[70]  George Georgiou,et al.  Viral assembly of oriented quantum dot nanowires , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[71]  J M Fox,et al.  Characterization of a disassembly deficient mutant of cowpea chlorotic mottle virus. , 1997, Virology.

[72]  J. Scott,et al.  Searching for peptide ligands with an epitope library. , 1990, Science.

[73]  D I Stuart,et al.  Evidence for the role of His-142 of protein 1C in the acid-induced disassembly of foot-and-mouth disease virus capsids. , 1999, The Journal of general virology.

[74]  D. Schaffer,et al.  Directed evolution of adeno-associated virus yields enhanced gene delivery vectors , 2006, Nature Biotechnology.

[75]  John E. Johnson,et al.  Virus particle maturation: insights into elegantly programmed nanomachines. , 2010, Current opinion in structural biology.

[76]  R. McKenna,et al.  Biochemical and physical characterization of parvovirus minute virus of mice virus-like particles. , 2000, Virology.

[77]  P. Grootenhuis,et al.  Structure-based design and protein engineering of intersubunit disulfide bonds in gonadotropins , 1997, Nature Biotechnology.

[78]  Werner Jaschke,et al.  Molecular imaging with nanoparticles: giant roles for dwarf actors , 2008, Histochemistry and Cell Biology.

[79]  Marianne Manchester,et al.  Viruses and their uses in nanotechnology , 2006 .

[80]  Nicole F Steinmetz,et al.  Utilisation of plant viruses in bionanotechnology. , 2007, Organic & biomolecular chemistry.

[81]  W. Stemmer,et al.  Molecular breeding of viruses , 2000, Nature Genetics.

[82]  Cristina Sánchez-Martínez,et al.  Functional Relevance of Amino Acid Residues Involved in Interactions with Ordered Nucleic Acid in a Spherical Virus* , 2005, Journal of Biological Chemistry.

[83]  Trevor Douglas,et al.  Viral capsids as MRI contrast agents , 2007, Magnetic resonance in medicine.

[84]  M. G. Mateu,et al.  Antibody recognition of picornaviruses and escape from neutralization: a structural view. , 1995, Virus research.

[85]  Marianne Manchester,et al.  Canine parvovirus-like particles, a novel nanomaterial for tumor targeting , 2006, Journal of nanobiotechnology.

[86]  M. Weitzman,et al.  Gene therapy: twenty-first century medicine. , 2005, Annual review of biochemistry.

[87]  Sek-Man Wong,et al.  Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin. , 2007, Bioconjugate chemistry.

[88]  Mauricio G. Mateu,et al.  A Single Amino Acid Substitution in the Capsid of Foot-and-Mouth Disease Virus Can Increase Acid Lability and Confer Resistance to Acid-Dependent Uncoating Inhibition , 2010, Journal of Virology.

[89]  Trevor Douglas,et al.  Synthesis of a cross-linked branched polymer network in the interior of a protein cage. , 2009, Journal of the American Chemical Society.

[90]  M S Chapman,et al.  The three-dimensional structure of canine parvovirus and its functional implications. , 1991, Science.

[91]  Trevor Douglas,et al.  Biological Containers: Protein Cages as Multifunctional Nanoplatforms , 2007 .

[92]  B. Kay,et al.  Selecting peptides for use in nanoscale materials using phage-displayed combinatorial peptide libraries. , 2005, Current opinion in biotechnology.

[93]  Maurizio Federico,et al.  Lentivirus-based virus-like particles as a new protein delivery tool. , 2010, Methods in molecular biology.

[94]  D. Clark,et al.  Solubilization and stabilization of bacteriophage MS2 in organic solvents , 2007, Biotechnology and bioengineering.

[95]  A. Plückthun,et al.  Beyond binding: using phage display to select for structure, folding and enzymatic activity in proteins. , 1999, Current opinion in structural biology.

[96]  C Russell Middaugh,et al.  Physical stabilization of Norwalk virus-like particles. , 2008, Journal of pharmaceutical sciences.

[97]  John E. Johnson Virus particle dynamics. , 2003, Advances in protein chemistry.

[98]  M. Young,et al.  Protein Engineering of a Viral Cage for Constrained Nanomaterials Synthesis , 2002 .

[99]  David V Schaffer,et al.  Molecular engineering of viral gene delivery vehicles. , 2008, Annual review of biomedical engineering.

[100]  Ki Tae Nam,et al.  Stamped microbattery electrodes based on self-assembled M13 viruses , 2008, Proceedings of the National Academy of Sciences.

[101]  P. Franzon,et al.  Electronic Properties of Molecular Memory Circuits on a Nanoscale Scaffold , 2007, IEEE Transactions on NanoBioscience.

[102]  D. Filman,et al.  Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. , 1989, The EMBO journal.

[103]  Alasdair C Steven,et al.  Crosslinking renders bacteriophage HK97 capsid maturation irreversible and effects an essential stabilization , 2005, The EMBO journal.

[104]  G. P. Smith,et al.  Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.

[105]  Trevor Douglas,et al.  Plant viruses as biotemplates for materials and their use in nanotechnology. , 2008, Annual review of phytopathology.

[106]  David Barlam,et al.  A stiffness switch in human immunodeficiency virus. , 2007, Biophysical journal.

[107]  Mauricio G. Mateu,et al.  Complete Alanine Scanning of Intersubunit Interfaces in a Foot-and-Mouth Disease Virus Capsid Reveals Critical Contributions of Many Side Chains to Particle Stability and Viral Function* , 2003, Journal of Biological Chemistry.

[108]  K D Wittrup Phage on display. , 1999, Trends in biotechnology.

[109]  Menahem Segal,et al.  Role of neurotrophins in central synapse formation and stabilization , 2002, Nature Reviews Neuroscience.

[110]  R. Garcea,et al.  Virus-like particles as vaccines and vessels for the delivery of small molecules. , 2004, Current opinion in biotechnology.

[111]  Gijs J. L. Wuite,et al.  Nanoindentation Studies Reveal Material Properties of Viruses , 2009 .

[112]  G. Wuite,et al.  Bacteriophage capsids: tough nanoshells with complex elastic properties. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[113]  G. Stubbs,et al.  Site-directed mutagenesis confirms the involvement of carboxylate groups in the disassembly of tobacco mosaic virus. , 1995, Virology.

[114]  John E. Johnson,et al.  Fluorescent signal amplification of carbocyanine dyes using engineered viral nanoparticles. , 2006, Journal of the American Chemical Society.

[115]  John E. Johnson,et al.  Icosahedral virus particles as addressable nanoscale building blocks. , 2002, Angewandte Chemie.

[116]  Alan R. Fersht,et al.  Redesigning enzyme structure by site-directed mutagenesis: tyrosyl tRNA synthetase and ATP binding , 1982, Nature.

[117]  Sek-Man Wong,et al.  In vitro-reassembled plant virus-like particles for loading of polyacids. , 2006, The Journal of general virology.

[118]  K. Jain,et al.  Nanotechnology in clinical laboratory diagnostics. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[119]  Angela M Belcher,et al.  Ordering of Quantum Dots Using Genetically Engineered Viruses , 2002, Science.

[120]  G. Weiss,et al.  Optimizing the affinity and specificity of proteins with molecular display. , 2006, Molecular bioSystems.

[121]  Marcos da Silva Freire,et al.  Effects of hydrostatic pressure on the stability and thermostability of poliovirus: a new method for vaccine preservation. , 2009, Vaccine.

[122]  Mato Knez,et al.  Viruses show their good side , 2006, Nature nanotechnology.

[123]  Malgorzata Milner,et al.  Virus‐Like Particles: Models for Assembly Studies and Foreign Epitope Carriers , 2005, Progress in Nucleic Acid Research and Molecular Biology.

[124]  P. Roy,et al.  Virus‑like particles as a vaccine delivery system: Myths and facts , 2008, Human vaccines.

[125]  W. Chiu,et al.  Structural biology of viruses , 1997 .

[126]  Priya Bondre,et al.  Structural details of the thermophilic filamentous bacteriophage PH75 determined by polarized Raman microspectroscopy. , 2005, Biochemistry.

[127]  Mauricio G Mateu,et al.  Role of interfacial amino acid residues in assembly, stability, and conformation of a spherical virus capsid. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[128]  Gijs J. L. Wuite,et al.  Scaffold expulsion and genome packaging trigger stabilization of herpes simplex virus capsids , 2009, Proceedings of the National Academy of Sciences.

[129]  Wadih Arap,et al.  Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors , 2003, Nature Biotechnology.

[130]  Mauricio G Mateu,et al.  Electrostatic repulsion, compensatory mutations, and long-range non-additive effects at the dimerization interface of the HIV capsid protein. , 2005, Journal of molecular biology.

[131]  Hiroshi Handa,et al.  Engineering of SV40-based nano-capsules for delivery of heterologous proteins as fusions with the minor capsid proteins VP2/3. , 2008, Journal of biotechnology.

[132]  Daniel W Pack,et al.  Engineering of a stable retroviral gene delivery vector by directed evolution. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[133]  George Georgiou,et al.  Virus-Based Toolkit for the Directed Synthesis of Magnetic and Semiconducting Nanowires , 2004, Science.

[134]  C. Russell Middaugh,et al.  Stabilization of measles virus for vaccine formulation , 2008, Human vaccines.

[135]  M. G. Mateu,et al.  The capillarity of nanometric water menisci confined inside closed-geometry viral cages , 2009, Proceedings of the National Academy of Sciences.

[136]  Mauricio G Mateu,et al.  Thermostable variants are not generally represented in foot-and-mouth disease virus quasispecies. , 2007, The Journal of general virology.

[137]  Mauricio G Mateu,et al.  Nuclear transport of trimeric assembly intermediates exerts a morphogenetic control on the icosahedral parvovirus capsid. , 2006, Journal of molecular biology.

[138]  F. Brown,et al.  Characterization of an acid-resistant mutant of foot-and-mouth disease virus. , 1995, Virology.

[139]  Trevor Douglas,et al.  Viruses: Making Friends with Old Foes , 2006, Science.

[140]  A. Plückthun,et al.  In vitro display technologies: novel developments and applications. , 2001, Current opinion in biotechnology.

[141]  Marianne Manchester,et al.  A Viral Nanoparticle with Dual Function as an Anthrax Antitoxin and Vaccine , 2007, PLoS pathogens.

[142]  Trevor Douglas,et al.  Paramagnetic viral nanoparticles as potential high‐relaxivity magnetic resonance contrast agents , 2005, Magnetic resonance in medicine.